Dexcom (DXCM) Receivables (2010 - 2026)
Dexcom (DXCM) posted quarterly Receivables of $1.3 billion for Q2 2026, down 6.46% year-over-year from $1.4 billion in Q2 2025, and up 15.57% quarter-over-quarter from $1.1 billion in Q1 2026.
Dexcom (DXCM) Receivables (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Receivables for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Receivables fell 6.46% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.3 billion (down 6.46% YoY), while the FY2025 annual figure was $1.2 billion, up 19.7% from the prior year.
- Receivables rose to $1.3 billion in Q2 2026 per DXCM's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Receivables topped out at $1.4 billion in Q2 2025 and bottomed at $554.8 million in Q1 2022.
- Historically, Receivables has averaged $938.5 million across 5 years, with a median of $990.0 million in 2023.
- Annual changes were most pronounced in 2024 — Receivables soared 53.12% — and 2026, when it retreated 6.46%.
- Dexcom's Receivables stood at $729.6 million in 2022, then surged by 35.86% to $991.2 million in 2023, then grew by 3.92% to $1.0 billion in 2024, then increased by 19.7% to $1.2 billion in 2025, then advanced by 3.62% to $1.3 billion in 2026.
- Business Quant data shows DXCM's Receivables at $1.3 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.2 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 1.77 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Bn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.23 Bn |
| Sep 30, 2025 | 1.13 Bn |
| Jun 30, 2025 | 1.37 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 959.20 Mn |
| Mar 31, 2024 | 988.70 Mn |
| Dec 31, 2023 | 981.90 Mn |
| Sep 30, 2023 | 794.50 Mn |
| Jun 30, 2023 | 759.80 Mn |
| Mar 31, 2023 | 645.70 Mn |
| Dec 31, 2022 | 722.30 Mn |
| Sep 30, 2022 | 572.80 Mn |
| Jun 30, 2022 | 570.10 Mn |
| Mar 31, 2022 | 554.80 Mn |
| Dec 31, 2021 | 523.90 Mn |
| Sep 30, 2021 | 538.30 Mn |